ArticleFrontiers in medicine2021

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model.

Zhuang Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.